| 10-EdAM | edatrexate |
| 111-Indium-ch806 | indium In 111 chimeric monoclonal antibody 806 |
| 111In-pertuzumab | indium In 111 pertuzumab |
| 11C-AMT | carbon C 11 alpha-methyltryptophan |
| (11C)dLop | carbon C 11 N-desmethyl-loperamide |
| 11C-MeAIB | carbon C 11 methylaminoisobutyrate |
| 11C-MET | methionine C 11 |
| 11C-PIB | carbon C 11 Pittsburgh compound B |
| 123I-IBZM | iolopride I-123 |
| 123I-MIBG | AdreView; iobenguane I 123; iodine I 123-metaiodobenzylguanidine |
| 123-I-MIP-1095 | iodine I 123 IMP-1095 |
| 124I-8H9 | iodine I 124 omburtamab |
| 124I-FIAU | iodine I 124 FIAU |
| 124I-MIBG | iodine I 124 iobenguane |
| [124I]-PU-AD | iodine I 124 PU-AD |
| 1,25(OH)2-D3 | calcitriol |
| 131-Cs | cesium Cs-131 |
| 131I-mAbF19 | I 131 monoclonal sntibody F19 |
| 131I-MIBG | Azedra; iobenguane I 131; iodine I 131-metaiodobenzylguanidine |
| 131I-MOAB CC49 | I 131 monoclonal antibody CC49 |
| 131I-MOAB CC49-deltaCH2 | iodine I 131 monoclonal antibody CC49-deltaCH2 |
| 131I-TF2 | iodine I 131-labeled anti-CEA/anti-HSG bispecific monoclonal antibody TF2 |
| 13C-dextromethorphan | carbon C 13 dextromethorphan |
| 13C-PE | carbon C 13 phytoene |
| 13C-PF | carbon C 13 phytofluene |
| 13-CRA | isotretinoin |
| 13NH3 | ammonia N-13 |
| [14C] oxaliplatin | carbon C 14 oxaliplatin |
| [14C] selumetinib | carbon C 14 selumetinib |
| [14C]-AVE8062 | carbon C 14 ombrabulin |
| 14C-E7080 | carbon C 14 lenvatinib mesylate |
| [14C]-roniciclib | carbon C 14 roniciclib |
| [15O]-H2O | water O-15 |
| 177 Lu-DOTA-TATE | lutetium Lu 177-dotatate |
| 177Lu-DOTA-cG250 | lutetium Lu-177 girentuximab |
| [177LuDOTA]-TOC | lutetium LU 177-edotreotide |
| 17-AAG | 17-N-allylamino-17-demethoxygeldanamycin; tanespimycin |
| 17-DMAG HCL | alvespimycin hydrochloride |
| 18 F-NaF | sodium fluoride F-18 |
| 18F fluoroglutamine | fluorine F 18-4-L-fluoroglutamine (2S,4R) |
| 18-F FPAC | fluorine F 18 fluoropaclitaxel |
| [18F] FPPRGD2 | 2-fluoropropionyl-labeled pegylated dimeric RGD peptide |
| [18F] FPRGD2 | 18F-labeled mini-PEG spacered RGD dimer |
| [18F]-6F-DA | fluorine F 18-6-fluorodopamine |
| 18F-ASIS | fluorine F 18-active site inhibited factor VIIa |
| 18F-aVb6-BP | fluorine F 18 alphaVbeta6-binding peptide |
| 18F-αvβ6-BP | fluorine F 18 integrin alpha v beta 6-targeted binding peptide |
| 18F-CA | fluorine F 18 clofarabine |
| 18F-choline | fluorine F 18 choline |
| 18F-DCFBC | fluorine F 18 DCFBC |
| 18F-DCFPyL | fluorine F 18 piflufolastat |
| 18FDG | fludeoxyglucose F 18 |
| 18F-EF5 | fluorine F 18-EF5 |
| 18F-ethylcholine | fluorine F 18 fluoroethylcholine |
| (18)F-FAC | 18-F-fluoroacetate |
| 18F-FAC | [18F]L-FAC |
| [18F]FACBC | fluciclovine F18 |
| 18F-FAZA | fluorine F 18-fluoroazomycin arabinoside |
| (18)F-FBnTP | fluorine F 18 fluorobenzyl triphenyl phosphonium |
| (18)F-FDHT | fluorine F 18 FDHT |
| 18F-FDOPA | fluorodopa F 18 |
| 18F-FES | 18F-16 alpha-fluoroestradiol; fluorine F 18-16 alpha-fluoroestradiol |
| 18F-FHBG | reporter probe 18F-FHBG |
| 18F-FLT | 18F-fluorothymidine; 3’-deoxy-3’-(18F) fluorothymidine; fluorine F 18-fluorothymidine |
| 18F-FMCH | 18F-choline; 18F-fluoromethylcholine; fluorine F 18-fluoromethylcholine |
| 18F-FMISO | 18F-fluoromisonidazole |
| 18F-FPAC | fluorine F 18 fluoropaclitaxel |
| [(18)F]F-PEG6-IPQA | fluorine F 18 fluoro-PEG6-IPQA |
| 18F-FPM | fluorine F 18-labeled S-(3-Fluoropropyl)homocysteine hydrochloride |
| [18F]FTT | fluorine F 18 fluorthanatrace |
| [18F]ISO-1 | Fluorine F 18 ISO-1 |
| [18F]L-FMAC | L-fluorine F 18-FMAC |
| 18F-MFBG | meta-fluorine F 18 fluorobenzylguanidine |
| 18F-MISO | 18F-fluoromisonidazole; fluorine F 18-fluoromisonidazole |
| [18F]-ML-10 | Fluorine F 18 ML-10 |
| [18F]SPA-RQ | [18F]-labeled substance P antagonist receptor quantifier |
| 18F-TFB | fluorine F 18 tetrafluoroborate |
| 1-MT | indoximod |
| 225Ac-J591 | actinium Ac 225 rosopatamab tetraxetan |
| 2-CdA | cladribine |
| 2-F-ara-AMP | fludarabine phosphate |
| 2ME2 | 2-methoxyestradiol |
| 2OHOA | idroxioleic acid |
| 32-P | phosphorus P32 |
| 3,4-DAP | amifampridine |
| 3,4-DHPEA | hydroxytyrosol |
| 3-AP | 3-aminopyridine-2-carboxaldehyde thiosemicarbazone; Triapine |
| 3-Apct | Triapine |
| 3D-CRT | 3-dimensional conformal radiation therapy; 3-dimensional radiation therapy |
| 3TC | lamivudine |
| 4-HC | perfosfamide |
| 4'-HPP | allopurinol |
| 4-HPR | fenretinide |
| 4-NQO | 4-nitroquinoline 1-oxide |
| 4-OHA | formestane |
| 4-OHT | afimoxifene |
| 4SCAR-FRa | autologous FRa-4SCAR-expressing T cells 4SCAR-FRa |
| 5,10-MTHF | folitixorin |
| 5-AC | azacitidine |
| 5-ALA | aminolevulinic acid |
| 5-ASA | mesalamine |
| 5-BrdU | broxuridine |
| 5-DFUR | doxifluridine |
| 5-FC | flucytosine |
| 5-FU | 5-fluorouracil |
| 5-FU injection | fluorouracil |
| 5-FU topical | topical fluorouracil |
| 5-FUDR | floxuridine |
| 5-FU-e TI | fluorouracil-e therapeutic implant |
| 5-HIAA | 5-hydroxyindoleacetic acid |
| 5-HTP | oxitriptan |
| 5-MTHF | L-methylfolate |
| 62Cu-ATSM | copper Cu 62-ATSM |
| 62Cu-ETS | copper Cu 62 ethylglyoxal bis(thiosemicarbazone) |
| 62Cu-PTSM | copper Cu 62-PTSM |
| 64Cu-DOTA-U3-1287 | copper Cu 64-DOTA-anti-HER3 monoclonal antibody U3-1287 |
| 67Cu-SARTATE | copper Cu 67 ucasareotide dasaroxetan |
| [68Ga]ABY-025 | gallium Ga 68-labeled affibody ABY-025 |
| (68)Ga-citrate | gallium Ga 68-citrate |
| 68Ga-DOTATATE | gallium Ga 68-DOTATATE |
| (68)Ga-DX600 | gallium Ga 68-labeled DX600 |
| [68Ga]MLN6907 | gallium Ga 68-labeled MLN6907 |
| 68Ga-NEB | gallium Ga 68-NEB |
| 68Ga-NOTA-AE105 | gallium Ga 68-NOTA-AE105 |
| 68Ga-NOTA-BBN-RGD | gallium Ga 68-NOTA-BBN-RGD |
| 68Ga-NOTA-NFB | gallium Ga 68-NOTA-NFB |
| 68Ga-Sgc8 | gallium Ga 68-NOTA-Sgc8 |
| 68Ga-THP-PSMA | gallium Ga 68-THP-PSMA |
| 6-AZUR | 6-azauridine |
| 6MHP | 6 melanoma helper peptide vaccine |
| 6-MP | mercaptopurine |
| 6R-MTHF | arfolitixorin |
| 6-TG | thioguanine |
| 765IGF-MTX | IGF-methotrexate conjugate |
| 7-OMEN | menogaril |
| 89Zr-bevacizumab | zirconium Zr 89-bevacizumab |
| 89Zr-DFO-J591 | zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591 |
| 89Zr-MMOT | zirconium Zr 89-labeled monoclonal antibody MMOT0530A |
| 89Zr-RO5323441 | zirconium Zr 89-labeled anti-PIGF monoclonal antibody RO5323441 |
| 89Zr-trastuzumab | zirconium Zr 89-trastuzumab |
| 8-Cl-Ado | 8-chloroadenosine |
| 8-Cl-cAMP | tocladesine |
| 8-MOP | methoxsalen |
| 90Y anti-CD45 MAb BC8 | yttrium Y 90 anti-CD45 monoclonal antibody BC8 |
| 90Y-DOTA-biotin | yttrium Y 90-DOTA-biotin |
| 90Y-DOTA-cG250 | yttrium Y 90-DOTA-girentuximab |
| 90-Y-IMP-288 | yttrium Y 90-DOTA-di-HSG peptide IMP-288 |
| 99mTc-3PRGD2 | technetium Tc 99m-3PRGD2 |
| 99mTc-EC20 | folate receptor-targeted technetium Tc 99m EC20 |
| 99mTc-EC-DG | technetium Tc 99m ethylenedicysteine-deoxyglucose |
| 99mTc-GP | technetium Tc 99m glycopeptide |
| 99mTc-MDP | technetium Tc 99m methylene diphosphonate |
| 9-AC | aminocamptothecin |
| 9-cRA | alitretinoin |
| 9-NC | rubitecan |